KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $91.4 million.

  • CareDx's Cash & Equivalents fell 415.62% to $91.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.4 million, marking a year-over-year decrease of 415.62%. This contributed to the annual value of $114.7 million for FY2024, which is 3952.94% up from last year.
  • CareDx's Cash & Equivalents amounted to $91.4 million in Q3 2025, which was down 415.62% from $68.2 million recorded in Q2 2025.
  • CareDx's 5-year Cash & Equivalents high stood at $353.1 million for Q3 2021, and its period low was $68.2 million during Q2 2025.
  • For the 5-year period, CareDx's Cash & Equivalents averaged around $148.8 million, with its median value being $93.3 million (2024).
  • As far as peak fluctuations go, CareDx's Cash & Equivalents soared by 86090.21% in 2021, and later crashed by 7650.43% in 2022.
  • Over the past 5 years, CareDx's Cash & Equivalents (Quarter) stood at $348.5 million in 2021, then plummeted by 74.2% to $89.9 million in 2022, then dropped by 8.59% to $82.2 million in 2023, then soared by 39.53% to $114.7 million in 2024, then dropped by 20.28% to $91.4 million in 2025.
  • Its last three reported values are $91.4 million in Q3 2025, $68.2 million for Q2 2025, and $88.7 million during Q1 2025.